These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7053413)

  • 21. Prostacyclin-induced coronary vasodilation. Interactions with adenosine, cyclic AMP and energy charge in the rat heart in vitro.
    Schrör K; Link HB; Rösen R; Klaus W; Rösen P
    Eur J Pharmacol; 1980 Jun; 64(4):341-8. PubMed ID: 6156077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on coronary vasodilator substances produced by myocardial metabolism].
    Matumoto M
    Kumamoto Igakkai Zasshi; 1970 Apr; 44(4):319-28. PubMed ID: 5468155
    [No Abstract]   [Full Text] [Related]  

  • 23. Relationship between oxygen tension, coronary vasodilation and prostaglandin biosynthesis in the isolated rabbit heart.
    Needleman P; Key SL; Isakson PC; Kulkarni PS
    Prostaglandins; 1975 Jan; 9(1):123-34. PubMed ID: 1135423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of dihydroergotoxin on myocardial capacitance vessels].
    Ovsiannikov VI
    Biull Eksp Biol Med; 1975 Jul; 80(7):52-4. PubMed ID: 819060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ibuprofen, pharmacokinetics and pharmacodynamics in the isolated rabbit heart.
    Askholt J; Nielsen-Kudsk F
    Acta Pharmacol Toxicol (Copenh); 1985 Feb; 56(2):99-107. PubMed ID: 3993392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Responses of the coronary arterial system of the horse to catecholamines.
    Webster JE; Bowie WC
    Am J Vet Res; 1971 Nov; 32(11):1677-85. PubMed ID: 5122147
    [No Abstract]   [Full Text] [Related]  

  • 27. [Influencing of oxygen pressure in the myocardium by coronary dilators].
    Kadatz R; Diederen W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):156-9. PubMed ID: 5804228
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of nitranol, nitropenton and nitrosorbid on the rate of the coronary blood flow and on the oxygen consumption of the myocardium].
    Buianov VV
    Farmakol Toksikol; 1967; 30(1):30-4. PubMed ID: 5594355
    [No Abstract]   [Full Text] [Related]  

  • 29. The specificity of prostaglandin E2 (PGE2) in reducing coronary vascular resistance: A comparison with adenosine.
    Schrör K; Berg-Becker M; Nookhwun C
    Basic Res Cardiol; 1978; 73(3):287-97. PubMed ID: 687323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukotriene D4: a potent sheep coronary vasoconstrictor not blocked by ibuprofen.
    Michelassi F; Landa L; Hill RD; Huttemeier P; Lowenstein E; Zapol WM; Watkins WD
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():397-9. PubMed ID: 6221552
    [No Abstract]   [Full Text] [Related]  

  • 31. A new vasoactive substance regulating the metabolic response of the coronaries.
    Szentiványi M; Juhász-Nagy A; Debreczeni L
    Acta Physiol Acad Sci Hung; 1967; 31(1):9-32. PubMed ID: 6079690
    [No Abstract]   [Full Text] [Related]  

  • 32. Coronary resistance increase by nondefatted albumin in saline-perfused rabbit hearts.
    Van Beek JH; Bouma P; Westerhof N
    Am J Physiol; 1990 Nov; 259(5 Pt 2):H1606-8. PubMed ID: 2240257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of aminophylline on the increased myocardial blood flow produced by systemic hypoxia or by coronary artery occlusion.
    Wadsworth RM
    Eur J Pharmacol; 1972 Oct; 20(1):130-2. PubMed ID: 4637941
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of flavon-7-ethyl oxyacetate on the cardiovascular system].
    Takenaka F; Takeya N; Tazume Y; Hayakawa T; Sakai M
    Kumamoto Igakkai Zasshi; 1967 Sep; 41(9):843-8. PubMed ID: 5631463
    [No Abstract]   [Full Text] [Related]  

  • 35. Myocardial ischemia due to dynamic small vessel coronary artery disease.
    Cannon RO
    Int J Cardiol; 1985 Feb; 7(2):198-203. PubMed ID: 3972478
    [No Abstract]   [Full Text] [Related]  

  • 36. [Relation between adenosine- and anoxia-induced myocardial lactate production].
    Szentmiklósi J; Mészáros J; Németh L; Fülöp L; Szegi J
    Acta Pharm Hung; 1979 May; 49(3):128-34. PubMed ID: 474136
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacologic viewpoint on so-called coronary dilator drugs].
    Faucon G; Evreux JC; Bazaugour R
    Therapie; 1970; 25(2):275-92. PubMed ID: 5526209
    [No Abstract]   [Full Text] [Related]  

  • 38. Rate of change in myocardial glycogen and lactic acid following arrest of coronary circulation.
    CONN HL; WOOD JC; MORALES GS
    Circ Res; 1959 Sep; 7():721-7. PubMed ID: 13811523
    [No Abstract]   [Full Text] [Related]  

  • 39. Coronary sinus blood flow during oxygen ventilation at 1 ATA and 3 ATA.
    Meijne NG; Straub JP
    Dis Chest; 1966 Aug; 50(2):161-72. PubMed ID: 5923666
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative effect of dihydrosamidine, pterixin and papaverine on the vessels in cholesterol-induced atherosclerosis of rabbits].
    Sharova GP
    Farmakol Toksikol; 1968; 31(3):284-7. PubMed ID: 5698107
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.